• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

Introduction to 5-Chloro-2-(methoxymethoxy)phenylboronic Acid (CAS No: 609352-56-9)

5-Chloro-2-(methoxymethoxy)phenylboronic acid is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound, identified by its Chemical Abstracts Service (CAS) number 609352-56-9, is characterized by its unique structural features, which include a chloro substituent and two methoxymethoxy groups attached to a phenyl ring. These structural attributes make it a versatile intermediate in organic synthesis, particularly in cross-coupling reactions such as the Suzuki-Miyaura coupling, which is widely employed in the construction of complex molecular architectures.

The significance of 5-Chloro-2-(methoxymethoxy)phenylboronic acid lies in its utility as a building block for the synthesis of various pharmacologically active molecules. Boronic acids, in general, are well-known for their ability to participate in reversible coordination with metals, which facilitates their role in catalytic processes. The presence of the chloro group on the phenyl ring enhances the electrophilicity of the boron center, making it more susceptible to nucleophilic attack during cross-coupling reactions. Additionally, the methoxymethoxy groups contribute to steric hindrance and electronic modulation, which can influence the reactivity and selectivity of the compound.

In recent years, there has been a surge in research focused on developing novel boronic acid derivatives for therapeutic applications. These derivatives are particularly relevant in the context of targeted drug delivery systems and biomaterials. For instance, 5-Chloro-2-(methoxymethoxy)phenylboronic acid has been explored as a precursor in the synthesis of boron-containing radiopharmaceuticals, which are used in positron emission tomography (PET) imaging for diagnostic purposes. The ability of boronic acids to form stable complexes with metal ions has also opened up avenues for their use in metal-organic frameworks (MOFs) and other advanced materials.

The synthesis of 5-Chloro-2-(methoxymethoxy)phenylboronic acid typically involves multi-step organic transformations, starting from readily available aromatic precursors. The chlorination step is crucial, as it introduces the electrophilic center necessary for subsequent functionalization. The methoxymethoxy groups are often introduced through nucleophilic substitution reactions or via protecting group strategies that ensure regioselectivity. The final product is characterized using spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography to confirm its structural integrity.

One of the most compelling aspects of 5-Chloro-2-(methoxymethoxy)phenylboronic acid is its role in enabling the synthesis of biaryl compounds, which are prevalent in many pharmaceuticals and agrochemicals. The Suzuki-Miyaura coupling reaction, facilitated by this boronic acid derivative, allows for the efficient formation of carbon-carbon bonds between aryl halides or triflates and boronic acids. This reaction has been instrumental in the development of novel therapeutic agents targeting various diseases, including cancer and infectious disorders.

Recent advancements in green chemistry have also highlighted the importance of sustainable synthetic methodologies for boronic acids. Researchers have been exploring catalytic systems that minimize waste and energy consumption while maintaining high yields and selectivity. For example, palladium-catalyzed cross-coupling reactions using water as a solvent or under mild conditions have been optimized for synthesizing 5-Chloro-2-(methoxymethoxy)phenylboronic acid derivatives. These innovations align with global efforts to promote environmentally friendly chemical processes.

The pharmacological potential of 5-Chloro-2-(methoxymethoxy)phenylboronic acid has not gone unnoticed by medicinal chemists. Preclinical studies have demonstrated that boron-containing compounds can exhibit significant biological activity by interacting with specific enzymes or receptors. The unique structural motifs present in this compound make it an attractive scaffold for designing molecules with enhanced binding affinity and reduced toxicity. Further research is ongoing to explore its efficacy in modulating pathways associated with inflammation, neurodegeneration, and metabolic disorders.

In conclusion, 5-Chloro-2-(methoxymethoxy)phenylboronic acid (CAS No: 609352-56-9) represents a valuable asset in modern synthetic chemistry. Its structural versatility and reactivity make it indispensable for constructing complex organic molecules with potential therapeutic applications. As research continues to uncover new synthetic strategies and pharmacological targets, this compound is poised to play an increasingly important role in drug discovery and materials science.

• 89694-48-4((5-chloro-2-methoxyphenyl)boronic acid)
• 762287-57-0((4-chloro-2-methoxyphenyl)boronic acid)
• 915201-07-9((3-chloro-5-methoxyphenyl)boronic acid)
• 1256355-51-7((2-Chloro-6-(methoxymethoxy)phenyl)boronic acid)
• 1256354-93-4(4,5-Dichloro-2-methoxyphenylboronic acid)
• 849062-29-9((5-Chloro-2-propoxyphenyl)boronic acid)
• 1256355-47-1(3-Chloro-2-(methoxymethoxy)phenylboronic acid)
• 352534-86-2(5-Chloro-2-ethoxyphenylboronic acid)
• 385370-80-9((2-chloro-6-methoxyphenyl)boronic acid)
• 179898-50-1((3-Chloro-2-methoxyphenyl)boronic acid)